FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313236943> ?p ?o ?g. }

• W4313236943 endingPage "2355" @default.
• W4313236943 startingPage "2344" @default.
• W4313236943 abstract "The DNA-repair enzyme Artemis is essential for rearrangement of T- and B-cell receptors. Mutations in DCLRE1C, which encodes Artemis, cause Artemis-deficient severe combined immunodeficiency (ART-SCID), which is poorly responsive to allogeneic hematopoietic-cell transplantation.We carried out a phase 1-2 clinical study of the transfusion of autologous CD34+ cells, transfected with a lentiviral vector containing DCLRE1C, in 10 infants with newly diagnosed ART-SCID. We followed them for a median of 31.2 months.Marrow harvest, busulfan conditioning, and lentiviral-transduced CD34+ cell infusion produced the expected grade 3 or 4 adverse events. All the procedures met prespecified criteria for feasibility at 42 days after infusion. Gene-marked T cells were detected at 6 to 16 weeks after infusion in all the patients. Five of 6 patients who were followed for at least 24 months had T-cell immune reconstitution at a median of 12 months. The diversity of T-cell receptor β chains normalized by 6 to 12 months. Four patients who were followed for at least 24 months had sufficient B-cell numbers, IgM concentration, or IgM isohemagglutinin titers to permit discontinuation of IgG infusions. Three of these 4 patients had normal immunization responses, and the fourth has started immunizations. Vector insertion sites showed no evidence of clonal expansion. One patient who presented with cytomegalovirus infection received a second infusion of gene-corrected cells to achieve T-cell immunity sufficient for viral clearance. Autoimmune hemolytic anemia developed in 4 patients 4 to 11 months after infusion; this condition resolved after reconstitution of T-cell immunity. All 10 patients were healthy at the time of this report.Infusion of lentiviral gene-corrected autologous CD34+ cells, preceded by pharmacologically targeted low-exposure busulfan, in infants with newly diagnosed ART-SCID resulted in genetically corrected and functional T and B cells. (Funded by the California Institute for Regenerative Medicine and the National Institute of Allergy and Infectious Diseases; ClinicalTrials.gov number, NCT03538899.)." @default.
• W4313236943 created "2023-01-06" @default.
• W4313236943 creator A5000732151 @default.
• W4313236943 creator A5004584198 @default.
• W4313236943 creator A5006746788 @default.
• W4313236943 creator A5008038245 @default.
• W4313236943 creator A5008869522 @default.
• W4313236943 creator A5013062959 @default.
• W4313236943 creator A5014774184 @default.
• W4313236943 creator A5015435191 @default.
• W4313236943 creator A5018762207 @default.
• W4313236943 creator A5024024533 @default.
• W4313236943 creator A5026642505 @default.
• W4313236943 creator A5035364106 @default.
• W4313236943 creator A5047178145 @default.
• W4313236943 creator A5052995460 @default.
• W4313236943 creator A5058799304 @default.
• W4313236943 creator A5060709363 @default.
• W4313236943 creator A5060988058 @default.
• W4313236943 creator A5062570333 @default.
• W4313236943 creator A5062929622 @default.
• W4313236943 creator A5069563469 @default.
• W4313236943 creator A5072814480 @default.
• W4313236943 creator A5073332649 @default.
• W4313236943 creator A5076379048 @default.
• W4313236943 creator A5081737757 @default.
• W4313236943 creator A5082949973 @default.
• W4313236943 creator A5084588074 @default.
• W4313236943 date "2022-12-22" @default.
• W4313236943 modified "2023-10-18" @default.
• W4313236943 title "Lentiviral Gene Therapy for Artemis-Deficient SCID" @default.
• W4313236943 cites W1480060525 @default.
• W4313236943 cites W1833217925 @default.
• W4313236943 cites W1973444244 @default.
• W4313236943 cites W1977089871 @default.
• W4313236943 cites W1986771731 @default.
• W4313236943 cites W1988484579 @default.
• W4313236943 cites W2028957578 @default.
• W4313236943 cites W2033604768 @default.
• W4313236943 cites W2036821908 @default.
• W4313236943 cites W2045995615 @default.
• W4313236943 cites W2055483827 @default.
• W4313236943 cites W2062428046 @default.
• W4313236943 cites W2065910655 @default.
• W4313236943 cites W2079473986 @default.
• W4313236943 cites W2092491768 @default.
• W4313236943 cites W2093535706 @default.
• W4313236943 cites W2097583590 @default.
• W4313236943 cites W2103873848 @default.
• W4313236943 cites W2148580811 @default.
• W4313236943 cites W2154794733 @default.
• W4313236943 cites W2161149487 @default.
• W4313236943 cites W2167473983 @default.
• W4313236943 cites W2341474073 @default.
• W4313236943 cites W2512114272 @default.
• W4313236943 cites W2779549603 @default.
• W4313236943 cites W2889412507 @default.
• W4313236943 cites W2891759323 @default.
• W4313236943 cites W2911443178 @default.
• W4313236943 cites W2937292311 @default.
• W4313236943 cites W2969994867 @default.
• W4313236943 cites W3108325785 @default.
• W4313236943 cites W3162626720 @default.
• W4313236943 cites W4220681985 @default.
• W4313236943 doi "https://doi.org/10.1056/nejmoa2206575" @default.
• W4313236943 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36546626" @default.
• W4313236943 hasPublicationYear "2022" @default.
• W4313236943 type Work @default.
• W4313236943 citedByCount "14" @default.
• W4313236943 countsByYear W43132369432022 @default.
• W4313236943 countsByYear W43132369432023 @default.
• W4313236943 crossrefType "journal-article" @default.
• W4313236943 hasAuthorship W4313236943A5000732151 @default.
• W4313236943 hasAuthorship W4313236943A5004584198 @default.
• W4313236943 hasAuthorship W4313236943A5006746788 @default.
• W4313236943 hasAuthorship W4313236943A5008038245 @default.
• W4313236943 hasAuthorship W4313236943A5008869522 @default.
• W4313236943 hasAuthorship W4313236943A5013062959 @default.
• W4313236943 hasAuthorship W4313236943A5014774184 @default.
• W4313236943 hasAuthorship W4313236943A5015435191 @default.
• W4313236943 hasAuthorship W4313236943A5018762207 @default.
• W4313236943 hasAuthorship W4313236943A5024024533 @default.
• W4313236943 hasAuthorship W4313236943A5026642505 @default.
• W4313236943 hasAuthorship W4313236943A5035364106 @default.
• W4313236943 hasAuthorship W4313236943A5047178145 @default.
• W4313236943 hasAuthorship W4313236943A5052995460 @default.
• W4313236943 hasAuthorship W4313236943A5058799304 @default.
• W4313236943 hasAuthorship W4313236943A5060709363 @default.
• W4313236943 hasAuthorship W4313236943A5060988058 @default.
• W4313236943 hasAuthorship W4313236943A5062570333 @default.
• W4313236943 hasAuthorship W4313236943A5062929622 @default.
• W4313236943 hasAuthorship W4313236943A5069563469 @default.
• W4313236943 hasAuthorship W4313236943A5072814480 @default.
• W4313236943 hasAuthorship W4313236943A5073332649 @default.
• W4313236943 hasAuthorship W4313236943A5076379048 @default.
• W4313236943 hasAuthorship W4313236943A5081737757 @default.
• W4313236943 hasAuthorship W4313236943A5082949973 @default.
• W4313236943 hasAuthorship W4313236943A5084588074 @default.

• next